CONNECT WITH US
HealthTech

HealthTech

DNA sequencing reveals how rare cancer spread between twins before birth

Medical Xpress logo

Published on

Add as a preferred source on Google
DNA sequencing reveals how rare cancer spread between twins before birth

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Two identical sisters came into the world carrying the same rare cancer. They lost their lives to an undifferentiated sarcoma, a soft-tissue cancer driven by a unique gene fusion (MN1::ZNF341). The story began before they were born, when pregnancy imaging picked up a tumor on Twin A's face. Then came the birth, when cancer deposits were found in both Twin A and Twin B. Researchers now had to work out how the cancer reached both girls. Did the cancer start on its own in each sister, or did it begin in one and pass to the other while they were still in the womb?

The researchers sequenced the entire genetic code of healthy and tumor tissues, along with placental samples, to trace the cancer's journey between the twins. All tumor samples from both twins carried a distinctive genetic signature belonging to Twin A.

The cancer likely began as a facial tumor in Twin A at the end of the first trimester, which was visible on scans before birth. The cancer then crossed the placenta to reach Twin B late in the second trimester.

Beyond tracing the cancer's spread, the findings challenged the classical model of how identical twins develop from an early embryo. These findings are published in Nature Communications.

Identical twins share the same starting point, developing from a single fertilized egg, but it is extremely unusual for both to develop the same cancer.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.